| Slab Example |
| Lorem ipsum dolor sit amet, elit magna aliqua. |
| Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Culpa qui officia deserunt mollit anim est laborum. |
| Lorem ipsum dolor sit amet, consectetur adipisicing elit. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
|
|
|
|
 |
| Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. |
|
|
|
| HCP - Here is an example of headline text and section that goes full width on mobile |
| Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. |
|
|
|
|
|
| Scroll to learn about my experience with Novoeight®. |
 |
| Here is an example of headline text and section that maintains its gutter on mobile |
| Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. |
|
|
|
| We can help with prescription costs and more.f |
| NovoSecure™ offers you support and education for managing life with hemophilia A. |
|
|
|
Access our
Trial Prescription Program.g |
| If you are eligible, we can help you get started on Esperoct® with the Novo Nordisk free Trial Prescription Program. |
| Call 1-844-668-6732 and talk with a NovoSecure™ specialist. |
|
| Lorem ipsum dolor sit amet |
| Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. |
|
Access our
Trial Prescription Program.g |
| Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. |
| Call 1-844-668-6732 |
|
|
| fNovo Nordisk Hemophilia and Rare Bleeding Disorders Copay/Coinsurance Terms and Conditions: Enrolled patients are eligible for up to $12,000 in co-pay/coinsurance assistance per calendar year for each NNI hemophilia or rare bleeding disorder product. Assistance is retroactive to 60 days. Patients must be commercially insured and may not be participating in any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance. Uninsured, cash-paying patients are not eligible to participate. Patients are eligible to receive co-pay/coinsurance assistance on an annual basis (12 months). Offer good only in the USA, Puerto Rico, Guam, Saipan, and Virgin Islands with participating pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law. The Savings Card will no longer be valid for residents of Massachusetts. Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. This is not an insurance program. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible. Must have a current prescription for an FDA-approved indication. |
| gPatients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product for an FDA-approved indication, and who have commercial insurance or who are uninsured, may be eligible to receive a limited supply of free product. Patients who participate in any government, state, or federally funded medical or prescription benefit program, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to receive product support. Product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product. |
|
|
|
| (Mobile) Full-Width image section |
 |
|
| Long-lasting protection against bleeds |
| Esperoct® keeps factor levels at or above 3% for 100% of the timeb,c and at or above 5% for 90% of time.b,d |
| Learn About Factor Levels > |
| Fewer infusions to manage |
| If you’re infusing every couple of days, you could cut your infusions by half switching to Esperoct®.e |
| Find Out How > |
| A factor that goes where you go |
| Whether it’s school, work, or an epic adventure, you can take Esperoct® along for the ride. It can be stored up to 104˚F for up to 3 months. |
| Get Going with Esperoct® > |
|
| Selected Important Safety Information |
| Lorem ipsum dolor Esperoct®? |
| |
• |
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
|
| Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.®? |
| |
• |
List item one: Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. |
|
| |
• |
List item two: Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Lorem ipsum dolor sit amet, consectetur adipisicing elit, apteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
| Esperoct®? |
| Esperoct® Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
| |
• |
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
|
| Important Safety Information (cont’d) |
| Esperoct® Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
| |
• |
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
|
| |
• |
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim est laborum. |
|
|
|
|
<%@ include view='hcpColoradoFooter' %>
|
| Please do not respond to this email. If you would like to contact us, please click here or call 1-800-727-6500. |
| UNSUBSCRIBE NOTICE |
| If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (e.g. name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement. |
|
Esperoct® is a registered trademark and NovoSecure™ is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2020 Novo Nordisk All rights reserved. US19ESP00150 April 2020 |
 |
|
|
|
![A photo of a pack of Esperoct [antihemophilic factor (recombinant), glycopegylated-exei] with the contents laid out around it, including a small vial of Esperoct® and the infusion equipment.](https://e2fe2a0a3ab3676591d8-6c5782e2c0470c249d1e2a209a9dea4b.ssl.cf2.rackcdn.com/rm-2020/rm-template-testing/esperoct-vial-imagery.jpg)